CN117247949A - Notoginseng disease course related protein 1 gene PnPR1-8 and its application - Google Patents
Notoginseng disease course related protein 1 gene PnPR1-8 and its application Download PDFInfo
- Publication number
- CN117247949A CN117247949A CN202311172500.9A CN202311172500A CN117247949A CN 117247949 A CN117247949 A CN 117247949A CN 202311172500 A CN202311172500 A CN 202311172500A CN 117247949 A CN117247949 A CN 117247949A
- Authority
- CN
- China
- Prior art keywords
- pnpr1
- gene
- tobacco
- related protein
- disease course
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 15
- 101150084750 1 gene Proteins 0.000 title claims abstract description 9
- 235000003143 Panax notoginseng Nutrition 0.000 title claims description 8
- 241000180649 Panax notoginseng Species 0.000 title claims description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 43
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 16
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 16
- 241001480714 Humicola insolens Species 0.000 claims abstract description 7
- 241000171741 Humicola fuscoatra Species 0.000 claims abstract description 4
- VYGYNVZNSSTDLJ-HKCOAVLJSA-N monorden Natural products CC1CC2OC2C=C/C=C/C(=O)CC3C(C(=CC(=C3Cl)O)O)C(=O)O1 VYGYNVZNSSTDLJ-HKCOAVLJSA-N 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 241000208125 Nicotiana Species 0.000 claims abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 38
- 241000196324 Embryophyta Species 0.000 abstract description 34
- 230000009261 transgenic effect Effects 0.000 abstract description 28
- 102000004169 proteins and genes Human genes 0.000 abstract description 20
- 239000013604 expression vector Substances 0.000 abstract description 7
- 208000031888 Mycoses Diseases 0.000 abstract description 6
- 230000002018 overexpression Effects 0.000 abstract description 3
- 206010017533 Fungal infection Diseases 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 40
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 11
- 239000013598 vector Substances 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000000246 agarose gel electrophoresis Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 101000611441 Solanum lycopersicum Pathogenesis-related leaf protein 6 Proteins 0.000 description 4
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 4
- 230000000843 anti-fungal effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000219195 Arabidopsis thaliana Species 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000012286 Chitinases Human genes 0.000 description 2
- 108010022172 Chitinases Proteins 0.000 description 2
- 241000223198 Humicola Species 0.000 description 2
- 241000549404 Hyaloperonospora parasitica Species 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 101710096342 Pathogenesis-related protein Proteins 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000021918 systemic acquired resistance Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 102100039339 Atrial natriuretic peptide receptor 1 Human genes 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000961044 Homo sapiens Atrial natriuretic peptide receptor 1 Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 101150060710 NPR1 gene Proteins 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 235000000365 Oenanthe javanica Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 241000233679 Peronosporaceae Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 241000589615 Pseudomonas syringae Species 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 235000007264 Triticum durum Nutrition 0.000 description 1
- 240000002805 Triticum turgidum Species 0.000 description 1
- 235000007247 Triticum turgidum Nutrition 0.000 description 1
- 241000209143 Triticum turgidum subsp. durum Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241001360088 Zymoseptoria tritici Species 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000012405 in silico analysis Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 238000003012 network analysis Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 244000000177 oomycete pathogen Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention discloses a pseudo-ginseng disease course related protein 1 gene PnPR1-8 and application thereof, wherein the nucleotide sequence of the PnPR1-8 gene is shown as SEQ ID NO:1, coding a disease course related protein 1, and confirming that the PnPR1-8 gene has the capability of improving plant fungal infection resistance through functional genomics related technical research, constructing the PnPR1-8 gene into a plant expression vector and transferring the plant expression vector into tobacco for overexpression, wherein the resistance of the PnPR1-8 transgenic tobacco to Humicola insolens (Humicola fuscoatra) is obviously improved.
Description
Technical Field
The invention belongs to the technical fields of molecular biology and genetic engineering, and particularly relates to a pseudo-ginseng disease course related protein 1 gene PnPR1-8 with antifungal infection capability and application thereof.
Background
During the whole growth of plants, they are subjected to stresses of various biotic and abiotic factors. Effector-triggered immunity (ETI) is an important component of natural plant immunity (Zhang J, zhou jm.plant immunity triggered by microbial molecular signature. Molecular plant.2010,3 (5): 783-793). This line of defense is activated when attacked by pathogens and a series of stress reactions such as ion flow exchange, production of reactive oxygen species and Salicylic Acid (SA) species, accumulation of secondary metabolites such as phytoalexins, tannins and phenolic compounds, synthesis of disease-associated Proteins (PRs) and the like (van Loon LC, rep M, pietessec M.Significa of inducibledefense-related proteins in infected plants. Annual review of bacteriology 2006, 44:135-162) occur.
PRs are a generic term for a class of proteins that plants are induced to produce and accumulate following biotic or abiotic stress, and were first discovered by van Loon et al in 1970 when tobacco (Nicotiana tabacum) leaves were infected with tobacco mosaic virus (van Loon LC, rep M, pieterse CM. Significa of inducibledefense-related proteins in infected plants. Annual review of phytodynamics.2006, 44:135-162). PRs are widely found in monocots and dicots, and some PR proteins exhibit potential antimicrobial activity in vitro and are associated with systemic acquired resistance (systemic acquired resistance, SAR) (Liu Y, liu Q, tang Y, et al, ntPR1a regulates resistance to Ralstonia solanacearumin Nicotiana tabacum via activating the defense-related genes, biochemical and biophysical research communications.2019,508 (3): 940-945). PR proteins are divided into 17 families according to characteristics of PR protein family in terms of structure, relationship and bioactivity (Kaur A, pati PK, pati AM, et al in-silico analysis of cis-acting regulatory elements of pathogenesis-related proteins of Arabidopsis thaliana and Oryza sativa. PLoS one.2017,12 (9): e 0184523). Plant PRs are of a wide variety of functions, such as transcription factors, protease inhibitors, antifungal agents, and the like. Some PRs also have hydrolase activities such as peroxidase, chitinase (Chitinase), and the like. PRs are distributed in relation to their isoelectric points and affinities, mainly in plant cell gaps and vacuoles (Jo BR, yu JM, jang S, et al cloning, expression, and purification of apathogenesis-related protein from Oenanthe javanica and its biological properties. Biological & pharmaceutical bulletin.2020,43 (1): 158-168).
Previous studies have demonstrated that PR proteins have inhibitory effects on the growth of many fungi. TdPR1.2 protein of PR1 family of Du Shixiao wheat (Triticum turgidum) has an inhibitory effect on the growth of the fungus Septoria tritici (septictrichl) (Ghorber M, zrtibi I, missaoui K, et al differential regulation of the durum wheat pathogenesis-related protein (PR 1) by cam module TdCaM1.3 protein. Molecular reports.2021,48 (1): 347-362). Constitutive high-efficiency expression of tobacco PR1-a enhances resistance to Phytophthora pathogens (Alexander D, goodman RM, gut-Rella M, et al, increased tolerance to two oomycete pathogens in transgenic tobacco expressing pathogenesis-modified protein 1a.Proceedings of the National Academy of Sciences of the United States of America.1993,90 (15): 7327-7331). Over-expression of the NPR1 gene into Arabidopsis thaliana (Arabidopsis thaliana) increased resistance to downy mildew (Peronospora parasitica) (Nandi A, kachroo P, fukushige H, et al, ethyl and jasmonic acid signaling affect the NPR1-independent expression of defense genes without impacting resistance to Pseudomonas syringae and Peronospora parasitica in the Arabidopsis ssi1 mutant. Molecular plant-micro interactions.2003,16 (7): 588-599).
Pseudo-ginseng [ Panax notoginseng (Burk) F.H.Chen ] has a long planting history and is mainly planted in southwest China. Notoginseng radix has extremely high medicinal value, has effects of promoting blood circulation, removing blood stasis, stopping bleeding, replenishing blood, and improving immunity of organism (Xie W, meng X, zhai Y, et al, panax notoginseng saponins: areview of its mechanisms of antidepressant or anxiolytic effects and network analysis on phytochemistry and pharmacology. Molecular.2018, 23 (4): 940), and in recent years, market demand of Notoginseng radix has been increasing. After the pseudo-ginseng is sown, the pseudo-ginseng is cultivated and grown for at least 3 years, and the root can be used as a medicine. In addition, pseudo-ginseng is a warm, moist and cool growing environment, but the unique planting environment causes pseudo-ginseng to suffer from various diseases and insect pests, and particularly fungus diseases typified by root rot often cause serious loss of yield and quality of pseudo-ginseng. In order to prevent and treat root rot, farmers kill soil in a large area or use a large amount of chemical pesticides, which not only increases the cost, but also causes environmental pollution easily due to the chemical agents (Wang Yong, ma Chengzhu, chenjun, etc. soil treatment has studied the control effect of root rot of pseudo-ginseng. Chinese journal of Chinese traditional medicine. 2008, (10): 1213-1214). One of the effective ways to solve the pseudo-ginseng disease is to cultivate resistant varieties, and resist fungal diseases through the defense reaction of plants.
Disclosure of Invention
The invention provides a disease course related protein 1 gene PnPR1-8 cloned from pseudo-ginseng, wherein the nucleotide sequence of the PnPR1-8 is shown as SEQ ID NO. 1, the ORF length of the gene is 702bp, and the protein with the amino acid sequence shown as SEQ ID NO. 2 is encoded.
The invention separates and clones the complete cDNA fragment of a antifungal related gene of pseudo-ginseng; transferring target genes into a receptor plant for overexpression through the mediation of agrobacterium tumefaciens (Agrobacterium tumefaciens); further experiments prove that whether the gene has antifungal activity or not, and lays a foundation for improving the capability of plants to resist fungal diseases by using the gene in the later period.
Another object of the present invention is to use the above-mentioned Notoginseng radix disease course related protein 1 gene PnPR1-8 in improving tobacco resistance to Humicola insolens (Humicola fuscoatra).
The operation of improving the antifungal property of tobacco by the pseudo-ginseng disease course related protein 1 gene PnPR1-8 is as follows:
(1) Extracting total RNA from pseudo-ginseng roots inoculated with PnPR1-8 by adopting a specific primer for amplifying PnPR1-8, amplifying ORF of PnPR1-8 by reverse transcription-polymerase chain reaction (reverse transcription-polymerase chain reaction, RT-PCR), connecting the ORF to pGEM-T vector, and sequencing to obtain clone with target gene;
(2) Cutting pGEM-T-PnPR1-8 vector and plant expression vector pCAMBIA2300s by using restriction enzymes EcoRI and BamHI, and recovering by gel to obtain target gene fragment and large vector fragment; then connecting the obtained PnPR1-8 gene fragment with a pCAMBIA2300s vector fragment to construct a plant super-expression vector; then transferring the constructed recombinant vector into tobacco for expression through the mediation of agrobacterium tumefaciens;
(3) And screening transformants by using a resistance marker on the recombinant vector T-DNA, obtaining positive transgenic plants by PCR and RT-PCR detection, analyzing the resistance of the transgenic plants to pathogenic fungi, and finally screening transgenic plants with obviously enhanced fungal resistance.
The invention provides a new method for improving the resistance of plants to fungal diseases, and the disease-resistant plants can be cultivated by a genetic engineering means to overcome the defects of traditional breeding, so that the breeding period is shortened, the operation is simple, and high-resistance materials are easy to obtain; the PnPR1-8 gene from pseudo-ginseng can enhance the resistance of plants to Humicola insolens, and the gene can be introduced into tobacco to generate new varieties and materials with fungal resistance. The cultivation of resistant plant varieties and materials by using genetic engineering technology has obvious advantages and irreplaceable importance; the invention not only can provide convenience for mass production of crops, flowers, medicinal materials and the like and reduce the use of chemical pesticides, but also can save cost and reduce environmental pollution for agricultural production, so that the invention has wide market application prospect.
Drawings
FIG. 1 is a PCR detection of a portion of the genomic DNA of PnPR1-8 transgenic tobacco according to the present invention, wherein Marker: DL2501 DNA Marker (Shanghai Jieli) is composed of five DNA fragments of 2,000bp, 1,000bp, 750bp, 500bp and 250 bp; positive control: PCR reaction with plasmid pGEM-T-PnPR1-8 as template; WT: PCR performed by taking non-transgenic tobacco (wild type) total DNA as a template;
FIG. 2 is a graph showing the results of expression analysis of PnPR1-8 transcription levels in partially positive PnPR1-8 transgenic tobacco according to the present invention, wherein Marker: DL2501 DNA Marker (Shanghai strapdown); WT: a PCR product taking non-transgenic tobacco total RNA reverse transcription cDNA as a template; positive control: PCR products with plasmid pGEM-T-PnPR1-8 as a template;
FIG. 3 is a graph showing the results of disease resistance identification of PnPR1-8 transgenic tobacco in the present invention; pnPR1-8 transgenic tobacco leaves inoculated with PnPR humicola insolens are shown; wherein WT is a wild type tobacco leaf, 8-6, 8-10, 8-11, 8-13 is a leaf of a PnPR1-8 transgenic tobacco strain.
Detailed Description
The present invention will be further illustrated by the following figures and examples, but the scope of the invention is not limited to the description, and the methods in this example are all performed according to the conventional methods unless otherwise specified, and the reagents used are the conventional reagents or the reagents configured according to the conventional methods unless otherwise specified.
Example 1: pnPR1-8 full-length cDNA clone and sequence analysis
Inoculating root tip of annual Notoginseng radix with mycelium of Pythium gracile (Humicola fuscoatra), collecting root 2 days after inoculation, and collecting rootThe Super total RNA extraction kit is used for extracting total RNA, measuring the concentration and performing agarose gel electrophoresis to analyze the quality of the total RNA.
Then Go ScriptTM Reverse Transcriptase System is adopted to synthesize a cDNA first strand by taking total RNA as a template, and the reaction system and the operation process are as follows: mu.g of total RNA was taken, 1. Mu.L of Oligo dT15 primer, 1. Mu.L of Random primer were added in this order, and the reaction volume was made up to 10. Mu.L with nucleic-Free Water; mixing, heating at 70deg.C for denaturation for 5min, cooling on ice for 5min, and sequentially adding 4 μL of 5×reaction Buffer and 4 μL of MgCl 2 (25mM)、1μL PCR Nucleotide Mix、0.4μL RecombinantRibonuclease Inhibitor, 0.4 mu L Reverse Transcriptase and 1.2 mu LNuclease-Free Water, mixing, centrifuging briefly, standing at 25deg.C for 5min, cooling in 42 deg.C for 1.5h, taking out, heating at 70deg.C for 10min, and stopping the reaction; the cDNA first strand is synthesized and then stored at-20 ℃ for standby.
By synthesis of cDNA NoOne strand is used as a template to amplify target genes PnPR1-8, and the used upstream and downstream primer sequences are 5 'ATGGGGTTTCTTAGTATCTCTC3' and 5 'TCAGCACGAACGGATATGCC3'; by TAKARAExAmplifying a target gene; PCR reaction conditions: 95 ℃ for 5min;95℃30s,60℃30s,72℃1min,30 cycles; 72 ℃ for 5min; the reaction system (50. Mu.L) was 2. Mu.L of cDNA, 5. Mu.L of 10 XEx Taq Buffer (Mg-containing) 2+ 20 mM), 4. Mu.L dNTP Mix (2.5 mM each), 1. Mu.L upstream primer (5. Mu.M), 1. Mu.L downstream primer (5. Mu.M), 0.25. Mu.L TaKaRa Ex Taq (5U/. Mu.L), 36.75. Mu.L ddH 2 O; after the PCR was completed, 50. Mu.L of the sample was subjected to 1% agarose gel electrophoresis to examine the specificity and size of the amplified product.
Detecting the PCR product band by electrophoresis, showing that the amplified product is a specific DNA band, and using SanPrep column type PCR product purification kit (Shanghai Ing) to cut gel and recycle to obtain the PCR amplified product; the recovered bands were then subjected to T-A cloning using pGEM-T Vector System I (TaKaRa), the reaction System and the procedure were: mu.L of PCR product was taken, and 0.7. Mu.L of pGEM-T vector, 0.9. Mu. L T4 DNALigase and 5. Mu.L of 2X Rapid Ligation Buffer were added in this order, and after mixing, they were allowed to react overnight at 16 ℃. The ligation product was transferred into E.coli DH 5. Alpha. Competence by heat shock transformation. Positive clones were screened with LB solid medium containing ampicillin (Amp). Selecting a plurality of single colonies in LB liquid medium containing Amp, and detecting cloning of the multiple cloning sites inserted into PnPR1-8 by using specific primers for amplifying PnPR1-8 after bacterial liquid is turbid. Sequencing the obtained positive clone, and analyzing that the final obtained PnPR1-8 full-length cDNA is 702bp through NCBIORF finder (http:// www.ncbi.nlm.nih.gov/gorf/gorf.html); pnPR1-8 encodes a protein of 233 amino acids having a molecular weight of about 25.55kDa and an isoelectric point of 8.48. Analysis of the protein sequence encoded by PnPR1-8 by means of bioinformatics software SignalP 4.1, detection of whether it has an N-terminal signal peptide, revealed the presence of a signal peptide at the N-terminal of PnPR1-8, and therefore the protein was presumed to be a secreted protein.
Example 2: construction of plant super-expression vector
The E.coli plasmid pGEM-T-PnPR1-8 inserted with the PnPR1-8 gene and the plant expression vector pCAMBIA2300s plasmid were extracted using SanPrep column type plasmid DNA miniprep kit (Shanghai) and 1. Mu.L was used for agarose gel electrophoresis to examine the integrity and concentration of the extracted plasmid. The recombinant plasmid pGEM-T-PnPR1-8 and the plant expression vector pCAMBIA2300s plasmid were simultaneously subjected to double digestion (50. Mu.L system) with restriction enzymes EcoRI (TaKaRa) and BamHI (TaKaRa) introduced in designing the primers; the reaction system and the operation process are as follows: respectively taking 15 mu LpGEM-T-PnPR1-8 and pCAMBIA2300s plasmids, and sequentially adding 7.5 mu L10 XK buffer, 2.5 mu L BamHI, 2.5 mu L LEcoI and 17.5 mu L ddH 2 O, after being evenly mixed, the mixture is centrifuged for a short time and is put into a water bath kettle at 37 ℃ for enzyme digestion for 3 hours. And (3) carrying out agarose gel electrophoresis on all enzyme-digested products, then respectively carrying out gel recovery on large fragments of PnPR1-8 ORF and pCAMBIA2300s vectors by using a SanPrep column type DNA gel recovery kit (Shanghai, inc.) (the specific operation steps are the same), taking 1 mu L of recovered products, detecting the size and concentration of the recovered fragments by agarose gel electrophoresis, and storing at-20 ℃ for later use.
The recovered PnPR1-8 DNA fragment and pCAMBIA2300s vector fragment were ligated by using T4 DNALigase (TaKaRa), the reaction system (20. Mu.L) and the procedure were: mu.L of PnPR1-8 ORF was taken and added with 2. Mu.L of pCAMBIA2300s vector DNA, 2. Mu.L of 10 XT 4 DNALigase Buffer, 1. Mu. L T4 DNALigase, 5. Mu.L of ddH in this order 2 O, after mixing evenly, centrifuging for a short time, and then carrying out a water bath at 16 ℃ for overnight reaction. The ligation product was then transferred into E.coli DH 5. Alpha. Using heat shock transformation, and positive clones were selected using solid medium containing 50mg/L kanamycin (kanamycin, kana). And (3) selecting a LB liquid medium containing 50mg/L Kana for single colony shake culture, using bacterial liquid as a template, carrying out PCR by using specific primers for amplifying PnPR1-8, selecting clones in which PnPR1-8 ORF and pCAMBIA2300s are successfully connected, adding glycerol into the detected positive strain, and storing at the temperature of-80 ℃ for later use.
Extracting and purifying pCAMBIA2300s-PnPR1-8 plasmid in the escherichia coli DH5 alpha, and transferring the recombinant plasmid pCAMBIA2300s-PnPR1-8 into the prepared competent cells of the agrobacterium tumefaciens LBA4404 by a liquid nitrogen freeze thawing method; the specific operation steps are as follows: adding 5 mu L of pCAMBIA2300s-PnPR1-8 plasmid into a centrifuge tube containing 50 mu L of competent cells, slightly mixing, ice-bathing for 30min, cooling in liquid nitrogen for 2min, rapidly placing in a water bath at 37 ℃ for 5min, ice-bathing for 2min, adding 500 mu L of LB liquid for shake culture at 28 ℃ for 4h; coating the activated agrobacterium on LB solid medium containing 50mg/LKana and 30mg/L Rif, and culturing at 28 ℃ in an inverted way; selecting a plurality of single colonies, shake culturing the single colonies in an LB liquid medium containing 50mg/LKana and 25mg/L Rif, performing PCR reaction by using a bacterial liquid as a template and then amplifying a specific primer of PnPR1-8, and detecting whether pCAMBIA2300s-PnPR1-8 is transferred into agrobacterium or not; for positive clones, glycerol was added and stored at-80℃until use.
Example 3: agrobacterium-mediated genetic transformation of tobacco and transgenic tobacco screening
The transgenic recipient for this experiment was tobacco (Nicotiana tabacum), and a batch of sterile tobacco seedlings was first cultured for genetic transformation experiments. Taking out the stored agrobacterium LBA4404 strain containing pCAMBIA2300s-PnPR1-8 plasmid from a refrigerator at the temperature of minus 80 ℃, inoculating 50 mu L of the strain into 50mL of LB liquid culture medium containing 50mg/L Kana and 30mg/L Rif, and culturing at the temperature of 28 ℃ until bacterial liquid is turbid; 1mL of the turbid bacterial solution was aspirated onto LB solid medium containing 50mg/L Kana and 30mg/L Rif, and cultured at 28℃for 48 hours. The agrobacteria on LB solid medium were then scraped off in appropriate amounts and inoculated into MGL liquid medium supplemented with 20mg/L Acetosyringone (AS) and cultured with shaking at 28℃for 4h to activate the agrobacteria.
Cutting young leaf of aseptic tobacco into pieces of about 1cm 2 Is completely soaked in the MGL liquid culture medium containing the activated agrobacterium, and is subjected to dip dyeing at 25 ℃ for 15min. Sucking the bacterial liquid on the surface of the leaf disc by using sterile filter paper, placing the leaf disc on a co-culture medium, and co-culturing for 2 days under the dark condition at 22 ℃; the co-culture medium for tobacco transformation is MS+0.02 mg/L6-BA+2.1 mg/L NAA+30g/L sucrose+6 g/L agar.
Transferring the co-cultured leaf discs into MS screening culture medium with antibiotic to differentiate into seedling, and screening transgenic plant. Tobacco screening medium is MS+0.5 mg/L6-BA+0.1 mg/L NAA+30g/L sucrose+6 g/L agar+50 mg/LKana+200mg/L cephalosporin (cefotaxime sodium salt, cef); the flask was transferred to an illumination incubator for cultivation (25 ℃,16h/d illumination, 8h/d darkness) during the screening cultivation. After differentiation and sprouting of tobacco, subculturing is performed with MS medium containing 50mg/L Kana and 200 mg/LCef. And (3) transferring the regenerated tobacco seedlings to an MS culture medium containing 50mg/L Kana to root the regenerated tobacco seedlings, and finally selecting regenerated tobacco seedlings with better roots for PCR analysis.
Extracting genome DNA of transgenic tobacco plant leaves by adopting a CTAB method, and carrying out PCR reaction by using the genome DNA as a template and using specific primers of PnPR 1-8; after the PCR is finished, 8 mu L of the product is used for agarose gel electrophoresis to detect positive transgenic plants; the amplification result of part of tobacco transgenic plants is shown in figure 1, and 36 positive transgenic plants are screened from PnPR1-8 transgenic tobacco.
Example 4: analysis of expression of PnPR1-8 in transgenic tobacco and analysis of function of transgenic plant against fungal infection
Extracting total RNA from young leaves of positive transgenic plants and non-transgenic tobacco (wild type) respectively, performing reverse transcription to generate a first cDNA chain (the specific operation steps are the same as above), performing PCR with the first cDNA chain as a template by using specific primers for amplifying PnPR1-8, and analyzing the expression level of PnPR1-8 in each transgenic plant according to the PCR result; total RNA extraction and RT-PCR were performed in the same manner as in example 1; after completion of PCR, 8. Mu.L was used for agarose gel electrophoresis, and the detection results of a part of the individual plants are shown in FIG. 2.
Laboratory-preserved Humicola insolens were inoculated on PDA solid medium (200 g/L potato, 15g/L agar, 20g/L glucose) and dark-cultured at 28℃for 5 days. WT tobacco and PnPR1-8 transgenic tobacco leaves grown well and uniform in size in the incubator and fully stretched were taken and cut from the petioles with surgical scissors. Wounds with the same size are formed at the same position of the blades by using a sterile plastic gun head, and the equal-size humicola insoles are respectively inoculated. The inoculated leaves are placed on filter paper soaked by sterile water, cultured in an illumination incubator at 28 ℃, and water is added every day for moisturizing. After 7d of culture, collecting the leaves and observing the disease condition of the leaves of each strain; as shown in FIG. 3, after being inoculated with Humicola insolens, leaves of wild type tobacco form larger lesions, the leaves are yellow and rotten, and the symptoms of transgenic tobacco leaves are lighter, so that the area of the formed lesions is far smaller than that of the wild type tobacco. Obviously, pnPR1-8 transgenic tobacco has obvious resistance to PnPR humicola.
Claims (2)
1. A Notoginseng radix disease course related protein 1 gene PnPR1-8 has a nucleotide sequence shown in SEQ ID NO. 1.
2. Use of the pseudo-ginseng disease course related protein 1 gene PnPR1-8 according to claim 1 for increasing resistance of tobacco to humicola insolens (Humicola fuscoatra).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311172500.9A CN117247949B (en) | 2023-09-12 | 2023-09-12 | Notoginseng disease course related protein 1 gene PnPR1-8 and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311172500.9A CN117247949B (en) | 2023-09-12 | 2023-09-12 | Notoginseng disease course related protein 1 gene PnPR1-8 and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117247949A true CN117247949A (en) | 2023-12-19 |
CN117247949B CN117247949B (en) | 2024-08-06 |
Family
ID=89132339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311172500.9A Active CN117247949B (en) | 2023-09-12 | 2023-09-12 | Notoginseng disease course related protein 1 gene PnPR1-8 and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117247949B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2746278A1 (en) * | 2012-12-19 | 2014-06-25 | Basf Se | Substituted [1,2,4]triazole and imidazole compounds |
CN104278039A (en) * | 2013-07-02 | 2015-01-14 | 中国中医科学院中药研究所 | Cloning of panax notoginseng and panax stipuleanatus disease-course correlated function genes |
CN107964547A (en) * | 2018-01-02 | 2018-04-27 | 昆明理工大学 | A kind of 10 gene PnPR10-3 of pseudo-ginseng pathogenesis-related proteins and application |
CN108251432A (en) * | 2018-01-02 | 2018-07-06 | 昆明理工大学 | Radix Notoginseng class PR gene PnPRlike and application |
CN109627303A (en) * | 2018-12-11 | 2019-04-16 | 昆明理工大学 | The gene of Radix Notoginseng pathogenesis-related proteins PnPR3 and its application |
WO2021090282A1 (en) * | 2019-11-08 | 2021-05-14 | Pi Industries Ltd. | Novel oxadiazole compounds containing fused heterocyclyl rings for controlling or preventing phytopathogenic fungi |
-
2023
- 2023-09-12 CN CN202311172500.9A patent/CN117247949B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2746278A1 (en) * | 2012-12-19 | 2014-06-25 | Basf Se | Substituted [1,2,4]triazole and imidazole compounds |
CN104278039A (en) * | 2013-07-02 | 2015-01-14 | 中国中医科学院中药研究所 | Cloning of panax notoginseng and panax stipuleanatus disease-course correlated function genes |
CN107964547A (en) * | 2018-01-02 | 2018-04-27 | 昆明理工大学 | A kind of 10 gene PnPR10-3 of pseudo-ginseng pathogenesis-related proteins and application |
CN108251432A (en) * | 2018-01-02 | 2018-07-06 | 昆明理工大学 | Radix Notoginseng class PR gene PnPRlike and application |
CN109627303A (en) * | 2018-12-11 | 2019-04-16 | 昆明理工大学 | The gene of Radix Notoginseng pathogenesis-related proteins PnPR3 and its application |
WO2021090282A1 (en) * | 2019-11-08 | 2021-05-14 | Pi Industries Ltd. | Novel oxadiazole compounds containing fused heterocyclyl rings for controlling or preventing phytopathogenic fungi |
Non-Patent Citations (4)
Title |
---|
LI, S等: "A Pathogenesis-Related Protein-Like Gene Is Involved in the Panax notoginseng Defense Response to the Root Rot Pathogen", FRONTIERS IN PLANT SCIENCE, vol. 11, 9 February 2021 (2021-02-09) * |
NCBI: "pathogenesis-related protein 1A-like [Coffea arabica]", NCBI, 4 December 2018 (2018-12-04), pages 027112702 * |
唐美琼;闵丹丹;李刚;蒋妮;叶云峰;: "三七病程相关蛋白PR10-1基因克隆及功能初步分析", 药学学报, no. 02, 12 February 2015 (2015-02-12) * |
李瑞博;崔秀明;刘玉忠;吴志刚;林淑芳;申业;黄璐琦;: "三七病程相关蛋白1基因的克隆与表达分析", 药学学报, no. 01, 12 January 2014 (2014-01-12) * |
Also Published As
Publication number | Publication date |
---|---|
CN117247949B (en) | 2024-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110818782B (en) | Lilium regale WRKY transcription factor gene LrWRKY3 and application thereof | |
CN108251432B (en) | Notoginseng disease course related protein genePnPRlikeAnd applications | |
CN110734482B (en) | Lilium regale WRKY transcription factor gene LrWRKY4 and application thereof | |
CN106244599B (en) | A kind of 1 family gene PnPR1-2 of Radix Notoginseng pathogenesis-related proteins and application | |
CN111235165B (en) | Lily susceptible fungal gene LrWRKY-S1 and application thereof | |
CN112831505A (en) | Pseudo-ginseng WRKY transcription factor genePnWRKY15And applications | |
CN112898391B (en) | Application of cold-resistant gene PtrERF9 of trifoliate orange in genetic improvement of cold resistance of plants | |
CN111454972B (en) | Hovenia dulcis cold-resistant gene PtrBADH and application thereof in plant cold-resistant genetic improvement | |
Yu et al. | Cloning and functional identification of PeWRKY41 from Populus× euramericana | |
CN113337536A (en) | Application of RS2Z32 gene as plant immune negative regulatory factor in improving crop resistance | |
CN108588041B (en) | Gossypium barbadense cytochrome P450 gene, and coding protein and application thereof | |
CN112359049B (en) | Lilium regale chitinase gene LrCHI2 and application thereof | |
CN106244598B (en) | Radix Notoginseng Dirigent albuminoid gene PnDIR1 and application | |
CN110592100B (en) | Cassava CAMTA gene and construction and disease-resistant application of suppression expression vector thereof | |
CN117286150B (en) | Notoginseng disease course related protein 1 gene PnPR1-3 and its application | |
CN107267525B (en) | Application of panax notoginseng polygalacturonase inhibitor protein gene PnPGIP | |
CN109295068B (en) | Pseudo-ginseng sweet protein gene PnTLP2 and application | |
CN108707614B (en) | Peanut stress resistance gene and application thereof | |
CN115340995B (en) | Mint drought-enduring gene McWRKY-like and expression protein and application thereof | |
CN117247949B (en) | Notoginseng disease course related protein 1 gene PnPR1-8 and its application | |
CN106434694B (en) | Application of cotton GbDREB gene in verticillium wilt resistance | |
CN112195178B (en) | Tomato late blight-resistant long-chain non-coding RNA-lncRNA40787, cloning method and application method thereof | |
CN116479034A (en) | Application of rice exoprotein Os05g01530.1 in rice blast fungus resistance | |
CN108707610B (en) | Notoginseng defensein antibacterial peptide genePnDEFL1And applications | |
CN113603757A (en) | Lilium regale Dirigent similar protein gene LrDI 1 and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |